OBJECTIVE: The mechanism whereby the placental cells of a human immunodeficiency virus (HIV)-1-infected mother protect the fetus from HIV-1 infection is unclear. Interferons (IFNs) inhibit the replication of viruses by acting at various stages of the life cycle and may play a role in protecting against vertical transmission of HIV-1. In addition the beta-chemokines RANTES (regulated on activation T cell expressed and secreted), macrophage inflammatory protein-1-alpha (MIP-1alpha), and MIP-1beta can block HIV-1 entry into cells by preventing the binding of the macrophage-trophic HIV-1 strains to the coreceptor CCR5. In this study the production of IFNs and beta-chemokines by placental trophoblasts of HIV-1-infected women who were HIV-1 non-transmitters was examined. METHODS: Placental trophoblastic cells were isolated from 29 HIV-1-infected and 10 control subjects. Supernatants of trophoblast cultures were tested for the production of IFNs and beta-chemokines by enzyme linked immunosorbent assay (ELISA). Additionally, HIV-1-gag and IFN-beta transcripts were determined by a semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) assay. RESULTS: All placental trophoblasts of HIV-1-infected women contained HIV-1-gag transcripts. There were no statistical differences in the median constitutive levels of IFN-alpha and IFN-gamma produced by trophoblasts of HIV-1 infected and control subjects. In contrast, trophoblasts of HIV-1-infected women constitutively produced significantly higher levels of IFN-beta protein than trophoblasts of control subjects. Furthermore, the median levels of beta-chemokines produced by trophoblasts of HIV-infected and control women were similar. CONCLUSIONS: Since there was no correlation between the placental HIV load and the production of interferons or beta-chemokines, the role of trophoblast-derived IFNs and beta-chemokines in protecting the fetus from infection with HIV-1 is not clear.
OBJECTIVE: The mechanism whereby the placental cells of a human immunodeficiency virus (HIV)-1-infected mother protect the fetus from HIV-1 infection is unclear. Interferons (IFNs) inhibit the replication of viruses by acting at various stages of the life cycle and may play a role in protecting against vertical transmission of HIV-1. In addition the beta-chemokines RANTES (regulated on activation T cell expressed and secreted), macrophage inflammatory protein-1-alpha (MIP-1alpha), and MIP-1beta can block HIV-1 entry into cells by preventing the binding of the macrophage-trophic HIV-1 strains to the coreceptor CCR5. In this study the production of IFNs and beta-chemokines by placental trophoblasts of HIV-1-infectedwomen who were HIV-1 non-transmitters was examined. METHODS: Placental trophoblastic cells were isolated from 29 HIV-1-infected and 10 control subjects. Supernatants of trophoblast cultures were tested for the production of IFNs and beta-chemokines by enzyme linked immunosorbent assay (ELISA). Additionally, HIV-1-gag and IFN-beta transcripts were determined by a semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) assay. RESULTS: All placental trophoblasts of HIV-1-infectedwomen contained HIV-1-gag transcripts. There were no statistical differences in the median constitutive levels of IFN-alpha and IFN-gamma produced by trophoblasts of HIV-1 infected and control subjects. In contrast, trophoblasts of HIV-1-infectedwomen constitutively produced significantly higher levels of IFN-beta protein than trophoblasts of control subjects. Furthermore, the median levels of beta-chemokines produced by trophoblasts of HIV-infected and control women were similar. CONCLUSIONS: Since there was no correlation between the placental HIV load and the production of interferons or beta-chemokines, the role of trophoblast-derived IFNs and beta-chemokines in protecting the fetus from infection with HIV-1 is not clear.
Authors: V Zachar; V Zacharova; T Fink; R A Thomas; B R King; P Ebbesen; T B Jones; A S Goustin Journal: AIDS Res Hum Retroviruses Date: 1999-12-10 Impact factor: 2.205
Authors: G Aboagye-Mathiesen; F D Tóth; P M Petersen; A Gildberg; N Nørskov-Lauritsen; V Zachar; P Ebbesen Journal: Placenta Date: 1993 Mar-Apr Impact factor: 3.481
Authors: K A McGann; R Collman; D L Kolson; F Gonzalez-Scarano; G Coukos; C Coutifaris; J F Strauss; N Nathanson Journal: J Infect Dis Date: 1994-04 Impact factor: 5.226
Authors: Eugenia de la Torre; Melissa J Mulla; Andrew G Yu; Seung-Joon Lee; Paula B Kavathas; Vikki M Abrahams Journal: J Immunol Date: 2009-03-15 Impact factor: 5.422
Authors: Jiahui Ding; Anthony Maxwell; Nicholas Adzibolosu; Anna Hu; Yuan You; Aihua Liao; Gil Mor Journal: Immunol Rev Date: 2022-03-20 Impact factor: 10.983
Authors: Karen S Coats; Crystal E Boudreaux; Brittany T Clay; Nikki N Lockett; Veronica L Scott Journal: Vet Immunol Immunopathol Date: 2009-10-14 Impact factor: 2.046
Authors: A Faye; S Pornprasert; J-Y Mary; G Dolcini; M Derrien; F Barré-Sinoussi; G Chaouat; E Menu Journal: Clin Exp Immunol Date: 2007-05-18 Impact factor: 4.330
Authors: Rose Bosire; Carey Farquhar; Ruth Nduati; Kristina Broliden; Stanley Luchters; Philippe Van de Perre; Isabelle De Vincenzi; Michele Merkel; Veronicah Wachuka; Dorothy Mbori-Ngacha; Grace John-Stewart; Barbara Lohman-Payne; Marie Reilly Journal: Pediatr Infect Dis J Date: 2018-03 Impact factor: 2.129